BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 1918462)

  • 41. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus.
    Cohen MR; Crosby D
    J Rheumatol; 1994 Sep; 21(9):1665-9. PubMed ID: 7799346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical analysis of chronic discoid and subacute cutaneous lupus erythematosus--relation to immunopathological mechanisms.
    Tebbe B; Mazur L; Stadler R; Orfanos CE
    Br J Dermatol; 1995 Jan; 132(1):25-31. PubMed ID: 7756149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Paraneoplastic subacute cutaneous lupus erythematosus].
    Rezazadegan R; Koushk-Jalali B; Kuntz T; Oellig F; Tigges C; Kreuter A
    Z Rheumatol; 2021 Mar; 80(2):189-193. PubMed ID: 33236165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitrendipine-induced subacute cutaneous lupus erythematosus.
    Marzano AV; Borghi A; Mercogliano M; Facchetti M; Caputo R
    Eur J Dermatol; 2003; 13(2):213-6. PubMed ID: 12695145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA-B8 in caucasian patients with systemic lupus erythematosus.
    Scherak O; Kolarz G; Mayr WR
    Scand J Rheumatol; 1978; 7(1):3-6. PubMed ID: 307811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis.
    Pantoja L; González-López MA; Bouso M; Alija A; Ortiz-Saracho J
    Scand J Rheumatol; 2002; 31(6):377-9. PubMed ID: 12492256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antinuclear antibody-keratinocyte interactions in photosensitive cutaneous lupus erythematosus.
    Furukawa F
    Histol Histopathol; 1999 Apr; 14(2):627-33. PubMed ID: 10212823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigens of the major histocompatibility complex in patients with chronic discoid lupus erythematosus.
    Knop J; Bonsmann G; Kind P; Doxiadis I; Vögeler U; Doxiadis G; Goerz G; Grosse-Wilde H
    Br J Dermatol; 1990 Jun; 122(6):723-8. PubMed ID: 2369554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subacute cutaneous lupus erythematosus lesions progressing to morphea.
    Rao BK; Coldiron B; Freeman RG; Sontheimer RD
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 2):1019-22. PubMed ID: 2229533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex.
    Bell DA; Rigby R; Stiller CR; Clark WF; Harth M; Ebers G
    J Rheumatol; 1984 Aug; 11(4):475-9. PubMed ID: 6332909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-A1, B8, DRw3 in patients with a distinct form of lupus erythematosus.
    Stastny P; Gilliam JN
    Transplant Proc; 1979 Dec; 11(4):1869-70. PubMed ID: 531931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histopathologic findings in cutaneous lupus erythematosus.
    Bielsa I; Herrero C; Collado A; Cobos A; Palou J; Mascaró JM
    Arch Dermatol; 1994 Jan; 130(1):54-8. PubMed ID: 8285740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Significant association of HLA-B8 with systemic lupus erythematosus and with specific serological markers].
    Specker C; Lakomek HJ; Kuntz BM; Bremer G; Goerz G; Krüskemper HL
    Dtsch Med Wochenschr; 1987 Apr; 112(15):577-80. PubMed ID: 3493893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Subacute cutaneous lupus erythematosus. Review of the literature and immunological studies of 11 patients].
    Fabbri P; Bernacchi E; Neri R
    G Ital Dermatol Venereol; 1990 Aug; 125(7-8):329-36. PubMed ID: 2289815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A clinical and epidemiological study of lupus erythematosus at a tertiary referral dermatology clinic in Korea.
    Bae YI; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
    Lupus; 2009 Dec; 18(14):1320-6. PubMed ID: 19884217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E; Wolska H; Blaszczyk M; Jablonska S
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenetic study of three Japanese families with neonatal lupus erythematosus.
    Nitta Y; Ikeya T; Santa T; Ohashi M; Usuda T
    J Dermatol; 1992 Apr; 19(4):223-8. PubMed ID: 1607484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.